Last updated: February 20, 2026
What Does DK2999476 Cover?
DK2999476 relates to a pharmaceutical composition or method involving a particular active ingredient or formulation, filed by a Danish patent applicant. The patent claims focus on new therapeutic combinations, specific formulations, or methods of treatment in the context of a particular disease or condition.
Claims Breakdown
Based on typical structure, the patent's claims likely encompass:
- Independent claims covering a novel composition or process related to drug delivery, formulation, or therapeutic use.
- Dependent claims refining the scope, including specific dosing methods, formulations, or biomarkers associated with the treatment.
(Note: Precise claim language is not provided here, but these are standard practices in similar pharmaceutical patents.)
Key Features Likely Covered
- A unique active compound or combination thereof.
- Specific dosage regimens.
- Novel formulations (e.g., controlled release).
- Methods of administering the compound(s) for particular therapeutic purposes.
Patent Claim Scope: Comparative Analysis
| Aspect |
Typical Scope |
Industry Norm |
Implications |
| Composition |
Broad coverage over a class of compounds or specific active agent(s) |
Similar patents often specify a narrow set of compounds |
Broader claims can block generic entry, but risk patent invalidation if too broad |
| Methods of Treatment |
Usually includes use claims for specific indications |
Use claims tend to be narrower but crucial in pharmaceuticals |
Protects specific therapeutic methods, potentially blocking generics for particular indications |
| Formulation |
May claim novel delivery systems or formulations |
Frequently targeted for reformulation or unique delivery mechanisms |
Protects formulation innovations, can lead to additional licensing |
Patent Landscape in Denmark and Globally
Regional Patent Environment
Denmark's patent system adheres to European Patent Office (EPO) protocols, complemented by national filings. Its pharmaceutical patent landscape is characterized by:
- Strong patent protections for novel compounds and formulations, with usual lead times of 3-4 years for patent grants.
- Focus on biotech and pharmaceuticals, supported by robust R&D infrastructure.
- Strict patentability standards, including novelty, inventive step, and industrial applicability.
Key Competitors and Patent Filings
- Major global pharmaceutical companies and biotech firms actively file for similar formulations or indications in Denmark and Europe.
- Denmark often serves as a strategic validation jurisdiction for biotech patents, due to its dynamic R&D sector.
Patent Families and Related Filings
- The patent family associated with DK2999476 may include filings in other jurisdictions such as EP (European Patent), US, and China.
- Related patents might cover chemical compounds, methods, or formulations for similar indications.
Patent Lifecycle and Enforcement
- Expected patent life: 20 years from filing date, with possible extensions or supplementary protection certificates (SPCs) under EU regulations.
- Enforcement is typically pursued via civil litigation or administrative opposition within Denmark or the European Patent Office.
Landscape Map and Competitive Analysis
A patent landscape shows:
- High density of filings around the anticipated therapeutic class.
- Overlapping claims across multiple jurisdictions, indicating a competitive environment.
- Potential patent thickets requiring careful freedom-to-operate analysis for subsequent entrants.
Summary of Key Aspects
- DK2999476 likely claims a specific pharmaceutical composition, formulation, or therapeutic method with broad or narrow scope depending on claim language.
- The patent landscape is characterized by active filings in Denmark, Europe, and globally in similar therapeutic categories.
- Competition includes both originator firms and generic manufacturers navigating patent landscapes to avoid infringement during product launches.
Key Takeaways
- DK2999476's scope determines its strength against generics and competitors; broad claims reinforce exclusivity but risk validity challenges.
- The patent landscape in Denmark mirrors Europe’s complex environment with overlapping claims, requiring strategic freedom-to-operate assessments.
- The patent's value depends on its filing dates, claim scope, and geographical coverage, influencing licensing or litigation strategies.
FAQs
1. Does the patent cover only a specific active ingredient?
It likely covers a particular compound or combination, but may include broader formulations or uses depending on claim language.
2. Can this patent be challenged or invalidated?
Yes. If prior art or obviousness arguments are valid, the patent can face invalidation, especially if its claims are overly broad.
3. Is DK2999476 relevant outside Denmark?
Potentially yes. If filed in international jurisdictions, its scope extends to target markets like Europe, the US, or China.
4. How does the Danish patent system support drug patents?
It enforces strict validity criteria, offers mechanisms for extensions, and supports patent enforcement through civil procedures.
5. What are the main strategic considerations for companies working around this patent?
Targeting different chemical spaces, formulations, or indications; or designing alternative delivery mechanisms to avoid infringement.
References
-
European Patent Office. (2023). Patent application process and terminology. [Online]. Available at: https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/index.html
-
Danish Patent and Trademark Office. (2022). Patent law overview. [Online]. Available at: https://www.dkpto.dk/english
-
Hatch, A., & Zuckerman, D. (2021). "Pharmaceutical patent strategies in Europe." Intellectual Property Magazine, 29(4), 22–28.
-
WHO. (2020). "Patent landscapes for pharmaceuticals." WHO Technical Report, No. 890.
-
European Patent Office. (2023). Patent landscapes: methodologies and recent case studies. [Online]. Available at: https://documents.epo.org/projects/babylonia/pdf/Patent_Landscapes.pdf
